Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CIBUS GLOBAL LTD.
CBUS | US
3.22
USD-0.11
-3.30%
CBUS | US
About CIBUS GLOBAL LTD.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
05/03/2026
Close
3.22
Open
3.31
High
3.35
Low
3.08
Cibus Inc. a agricultural technology company develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego California.
View LessCBUS | US
Risk
172.0
Sharpe
0.54
Luna's Score
43/100
Recommendation
Sell
Luna says (CBUS | US)
What's Working
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
99.6%1 month
172.0%3 months
132.9%6 months
109.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.34
Debt to equity
0.81
Debt to assets
0.40
Ent. to EBITDA
-1.15
Ent. to rev.
33.41
PEG
-
Other Fundamentals
EBITDA
-67.07M
MarketCap
94.96M
MarketCap(USD)
94.96M
Div. yield
-
Op. margin
-2.56K
Erngs. growth
-
Rev. growth
325.40
Ret. on equity
-79.11
Short ratio
6.41
Short perc.
12.39
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.97
Range1M
1.91
Range3M
2.34
Volumes: Market Activity
Rel. volume
0.56
Price X volume
1.04M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.15 | 0.53 | Cheaper |
| Ent. to Revenue | 33.41 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.34 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 132.90 | 72.80 | Riskier |
| Debt to Equity | 0.81 | -1.23 | Expensive |
| Debt to Assets | 0.40 | 0.25 | Expensive |
| Market Cap | 94.96M | 3.66B | Emerging |
